AN IMPORTANT COMPONENT OF BASIC THERAPY IN CYSTIC FIBROSIS (MUCOVYSCIDOSIS) IN CHILDREN: DORNASE ALFA
Dornase alpha plays an important role in the basic treatment of cystic fibrosis, having three clinical effects: powerful mucolytic, anti-inflammatory and antibacterial. Early drug inclusion and its permanent administration in the basic therapy allows patients with cystic fibrosis to have an active l...
Saved in:
Main Author: | O.I. Simonova (Author) |
---|---|
Format: | Book |
Published: |
Union of pediatricians of Russia,
2011-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
AN IMPORTANT COMPONENT OF BASIC THERAPY IN CYSTIC FIBROSIS (MUCOVYSCIDOSIS) IN CHILDREN: DORNASE ALFA
by: O.I. Simonova
Published: (2011) -
PECULIARITIES OF DORNASE ALFA AND KINESITHERAPY USE IN CHILDREN WITH CYSTIC FIBROSIS
by: O. I. Simonova
Published: (2013) -
DORNASE ALFA IN RUSSIA: 15 YEARS LATER. EFFICACY OF THE DRUG IN THE BASIC TREATMENT IN CHILDREN WITH CYSTIC FIBROSIS
by: O. I. Simonova, et al.
Published: (2012) -
OPPORTUNITIES OF DORNASE ALFA IN PEDIATRICS
by: O.I. Simonova
Published: (2011) -
OPPORTUNITIES OF DORNASE ALFA IN PEDIATRICS
by: O.I. Simonova
Published: (2011)